| An aggressive programme of measles immunisation across the
Americas seems to have paid off, only two years behind schedule. The
Pan-American Health Organization (PAHO) is now reporting an unprecedented
two-month absence of any locally transmitted measles infections. In 1994,
there were 250,000 cases in the region.
Across most of the Americas, the measles vaccination rate is now higher
than 80 per cent. The WHO estimates that a 95 per cent vaccination rate is
necessary for full national immunity. But PAHO officials hope that if
vaccination levels can be maintained or improved, they will be sufficient to
keep a check on any future outbreak caused by an infected visitor to the
continent.
The success of the programme is partly down to price cuts in measles
vaccines, now down to about 10 cents per shot. It will give hope to a
recently launched measles vaccination initiative in Africa - the last major
stronghold of infection - where one child dies from the disease every
minute. The achievement also suggests that global measles eradication is
possible, says a PAHO vaccination expert.
Measles is one of the most infectious known diseases. It remains the
leading cause of death due to an illness that can be prevented with a
vaccine. In 1994, delegates at a Pan American Sanitary Conference agreed a
three-stage attack on the virus, with the aim of stopping locally
transmitted infections in the region by 2000.
Rapid spread
The first stage was to vaccinate all children aged between nine months
and 14 years. The next stage involved routine vaccination of all children
aged over one year. And the final stage was to mass-vaccinate children aged
under four every four years, in an attempt to maintain widespread
protection.
In 1996, the number of cases in the Americas had dropped to 2106. In
1997, an outbreak in Sao Paulo spread rapidly, infecting more than 52,000
people in Brazil alone. But by 1999, sustained vaccination brought the
annual regional total back to 3209. There have now been no new locally
transmitted cases since 20 September 2002.
It is essential that vaccination rates remain high, to protect against
imported cases from countries with low vaccine coverage, says the PAHO.
MMR fears
| |
| |
|
Related Stories
|
| |
|
|
| |
|
|
| |
|
|
| |
| |
For more related stories
search the print edition
Archive
|
| |
| |
|
Weblinks
|
| |
|
|
| |
|
|
| |
|
|
| |
| |
In February, a consortium of five leading global health organisations,
including the World Health Organization and the PAHO, launched the Measles
Initiative, which will initially focus on vaccinating 200 million children
in Africa, with the aim of saving 1.2 million lives over five years.
Ciro de Quadros, a consultant to the PAHO, says that if Latin America can
demonstrate an absence of locally acquired cases for a sustained period of
at least two years, a global measles eradication programme should be
launched.
But global eradication will also require a willingness of parents in
developed countries to vaccinate their children against measles. Recent
fears over the triple action measles, mumps and rubella (MMR) vaccine in the
UK have to a drop in levels of measles protection.
Currently in the UK, just 84 per cent of children aged two years have
received the MMR jab, down from 92 per cent in 1995. In London, the figure
is now just 72 per cent. |